CORRESP Filing
Enlivex Ltd.
Date: May 8, 2025 · CIK: 0001596812 · Accession: 0001213900-25-041042
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286956
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Attention: Tyler Howes RE: Enlivex Therapeutics Ltd. (the "Company") Registration Statement on Form F-3 (the "Registration Statement") Filed May 2, 2025 File No. 333-286956
Dear Mr. Howes:
The Company hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the Registration Statement so that such Registration Statement will become effective as of 4:00 p.m. on May 12, 2025, or as soon thereafter as practicable.
[Signature page follows]
Very truly yours,
Enlivex Therapeutics Ltd .
Show Raw Text
CORRESP 1 filename1.htm Enlivex Therapeutics Ltd. 14 Einstein Street Ness Ziona Israel 7403618 May 8, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Attention: Tyler Howes RE: Enlivex Therapeutics Ltd. (the "Company") Registration Statement on Form F-3 (the "Registration Statement") Filed May 2, 2025 File No. 333-286956 Dear Mr. Howes: The Company hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the Registration Statement so that such Registration Statement will become effective as of 4:00 p.m. on May 12, 2025, or as soon thereafter as practicable. [Signature page follows] Very truly yours, Enlivex Therapeutics Ltd . By: /s/ Shai Novik Name: Shai Novik Title: Chairman of the Board of Directors